# Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma

> **NCT07202156** · NA · RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 35 (estimated)

## Conditions studied

- Melasma (Facial Melasma)

## Interventions

- **DEVICE:** 10%TXA+2%Reduced Glutathione applied via ultrasound at 5W/cm² in10min
- **OTHER:** 10%TXA+2%Reduced Glutathione applied via ultrasound at 0W/cm² 10min

## Key facts

- **NCT ID:** NCT07202156
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-20
- **Primary completion:** 2026-02-07
- **Final completion:** 2026-02-25
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07202156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07202156, "Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07202156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*